Complimentary shipping over $150 · Join Aurevia One for member pricing · NuraProof early access is open
Research Integrity

What we promise, and how to hold us to it.

The principles that govern how AES conducts evidence review, discloses conflicts, handles negative findings and corrects the record.

01

Transparency

Disclose corporate ownership, commercial interests and study funding.

02

Reproducibility

Maintain methods, search records, formula versions and analysis decisions.

03

Negative findings

Do not suppress unfavourable or inconclusive findings.

04

Separation of functions

Commercial teams may request research questions but must not alter scientific conclusions.

05

Conflicts of interest

Display relevant financial and professional conflicts.

06

Version control

Maintain previous evidence summaries and explain material changes.

07

Human review

Scientific and safety-sensitive content is reviewed by appropriately qualified people.

08

No paid evidence scores

Suppliers, product brands and commercial partners cannot purchase a higher evidence classification.

09

No fabricated authority

Do not imply endorsement by regulators, universities, clinicians or laboratories.

10

Corrections

Provide a visible correction mechanism and change log.

Corrections

See a claim you'd like us to re-examine?

Report an Evidence Concern
DisclosureAll concerns are logged, reviewed and — where a correction is required — surfaced in a public change log.